Predictors and Outcomes of In-hospital HFpEF in AMI Patients
Predictors and Outcomes of Hospitalized Heart Failure With Preserved Ejection Fraction Among Patients With First Acute Myocardial Infarction After Reperfusion Treatments
1 other identifier
observational
500
1 country
1
Brief Summary
This retrospective observation is to investigate the incidence,clinical outcomes and prognosis of hospitalized heart failure with preserved ejection fraction (HFpEF) in patients with acute myocardial infarction(AMI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 4, 2017
CompletedFirst Posted
Study publicly available on registry
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedJanuary 2, 2019
December 1, 2018
6 years
November 4, 2017
December 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk factors of incident in-hospital HFpEF
Outcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.
Secondary Outcomes (1)
Clinical prognosis in patients with HFpEF
Outcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.
Study Arms (2)
AMI patients with HFpEF
AMI patients without HF
Interventions
The differences of data(clinical characteristics, history, laboratory biomarkers, echocardiographic measurements, angiographic characteristics and clinical outcomes) in two groups were conducted. The differences between two groups were compared (clinical characteristics, history, laboratory biomarkers, echocardiographic measurements, angiographic characteristics and clinical outcomes) in two groups were compared, and then found the risk factors. Following,the incidence of clinical outcomes and mortality were compared. Then, univariate logistic regression and multivariate logistic regression analysis adjusted for significant risk factors were performed to find out the independent predictive factors. Finally, the ROC was constructed, and the area was evaluated to assess the predicted probability of regression model.
Eligibility Criteria
AMI patients with HFpEF: First AMI subjects undergoing PCI with a diagnosis of HFpEF. AMI patients without HF: First AMI subjects undergoing PCI without a diagnosis of HF.
You may qualify if:
- First AMI patients undergoing PCI with HFpEF or without HF.
You may not qualify if:
- First AMI patients with heart failure with reduced ejection fraction.
- First AMI patients with severe inflammatory diseases, valvular heart disease, non-cardiac caused symptoms, serious hepatic and renal failure, congenital cardiomyopathy,or pericardial diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xiangjun Yanglead
Study Sites (1)
the First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
Study Officials
- PRINCIPAL INVESTIGATOR
Xiangjun Yang, PhD
First Affiliated Hospital of Soochow University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director, department of cardiology
Study Record Dates
First Submitted
November 4, 2017
First Posted
November 22, 2017
Study Start
January 1, 2013
Primary Completion
December 30, 2018
Study Completion
December 30, 2018
Last Updated
January 2, 2019
Record last verified: 2018-12